Evidence map›Paper›PMID 38038790›Full record

ArticleAnnals of surgical oncology2024

Impact of Hepatic Pedicle Clamping on Long-Term Survival Following Hepatectomy for Hepatocellular Carcinoma: Stratified Analysis Based on Intraoperative Blood Transfusion Status.

Shi-Chuan Tang, Jia-Hao Xu, Yi-Fan Yang, Jia-Ning Shi, Kong-Ying Lin, Jie Kong, Xian-Ming Wang, Zhong-Qi Fan, Wei-Min Gu, Ya-Hao Zhou and 6 more

Abstract readMulticenter Study
PubMed Publisher
In one paragraph

Article in Annals of surgical oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.0field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors at 15 institutions in 1 country.

Shi-Chuan TangDepartment of Hepatobiliary Surgery, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, Fujian Province, China.
Jia-Hao XuDepartment of Hepatobiliary Surgery, Eastern Hepatobiliary Surgery Hospital, Navy Medical University (Second Military Medical University), Shanghai, China.
Yi-Fan YangDepartment of Hepatobiliary Surgery, Affiliated Hospital of Nantong University, Jiangsu, China.
Jia-Ning ShiDepartment of Gastroenterology, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, China.
Kong-Ying LinDepartment of Hepatobiliary Surgery, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, Fujian Province, China.
Jie KongDepartment of Hepatobiliary, Heze Municiple Hospital, Shandong, China.
Xian-Ming WangDepartment of General Surgery, First Affiliated Hospital of Shandong First Medical University and Shandong Provincial Qianfoshan Hospital, Shandong, China.
Zhong-Qi FanDepartment of Hepatobiliary and Pancreatic Surgery, General Surgery Center, First Hospital of Jilin University, Changchun, China.
Wei-Min GuThe First Department of General Surgery, Fourth Hospital of Harbin, Heilongjiang, China.
Ya-Hao ZhouDepartment of Hepatobiliary Surgery, Pu'er People's Hospital, Pu'er, China.
Hong-Zhi LiuDepartment of Hepatobiliary Surgery, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, Fujian Province, China.
Ying-Jian LiangDepartment of Hepatobiliary Surgery, First Affiliated Hospital of Harbin Medical University, Heilongjiang, China.
Feng ShenDepartment of Hepatobiliary Surgery, Eastern Hepatobiliary Surgery Hospital, Navy Medical University (Second Military Medical University), Shanghai, China.
Wan Yee LauDepartment of Hepatobiliary Surgery, Eastern Hepatobiliary Surgery Hospital, Navy Medical University (Second Military Medical University), Shanghai, China.
Yong-Yi ZengDepartment of Hepatobiliary Surgery, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, Fujian Province, China. lamp197311@126.com.
Tian YangDepartment of Hepatobiliary Surgery, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, Fujian Province, China. yangtiandfgd@hotmail.com.
First Affiliated Hospital of Fujian Medical University · CNChinese University of Hong Kong · CNEastern Hepatobiliary Surgery Hospital · CNFirst Hospital of Jilin University · CNFourth Affiliated Hospital of Harbin Medical University · CNFujian Medical University · CNHarbin Medical University · CNHeze Municipal Hospital · CNJilin University · CNMengchao Hepatobiliary Hospital · CNNantong University · CNPuer University · CNSecond Military Medical University · CNShandong Provincial QianFoShan Hospital · CNShanghai East Hospital · CN

Funding

National Natural Science Foundation of China 62275050Shanghai Outstanding Academic Leader Program 23XD1424900The Key Clinical Specialty Discipline Construction Program of Fuzhou, Fujian 201912002the Major Research Projects for Young and Middle-aged Talent of Fujian Provincial Health Commission 2021ZQNZD013
6 · The paper itself

Abstract

backgroundHepatic pedicle clamping (HPC) is frequently utilized during hepatectomy to reduce intraoperative bleeding and diminish the need for intraoperative blood transfusion (IBT). The long-term prognostic implications of HPC following hepatectomy for hepatocellular carcinoma (HCC) remain under debate. This study aims to elucidate the association between HPC and oncologic outcomes after HCC resection, stratified by whether IBT was administered. PATIENTS AND

methodsProspectively collected data on patients with HCC who underwent curative resection from a multicenter database was studied. Patients were stratified into two cohorts on the basis of whether IBT was administered. The impact of HPC on long-term overall survival (OS) and recurrence-free survival (RFS) between the two cohorts was assessed by univariable and multivariable Cox regression analyses.

resultsOf 3362 patients, 535 received IBT. In the IBT cohort, using or not using HPC showed no significant difference in OS and RFS outcomes (5-year OS and RFS rates 27.9% vs. 24.6% and 13.8% vs. 12.0%, P = 0.810 and 0.530). However, in the non-IBT cohort of 2827 patients, the HPC subgroup demonstrated significantly decreased OS (5-year 45.9% vs. 56.5%, P < 0.001) and RFS (5-year 24.7% vs. 33.3%, P < 0.001) when compared with the subgroup without HPC. Multivariable Cox regression analysis identified HPC as an independent risk factor of OS and RFS [hazard ratios (HR) 1.16 and 1.12, P = 0.024 and 0.044, respectively] among patients who did not receive IBT.

conclusionsThe impact of HPC on the oncological outcomes following hepatectomy for patients with HCC differed significantly whether IBT was administered, and HPC adversely impacted on long-term survival for patients without receiving IBT during hepatectomy.

Indexed as

Carcinoma, HepatocellularLiver NeoplasmsBlood TransfusionConstrictionHepatectomyHumansPrognosisRetrospective StudiesHepatectomyHepatic pedicle clampingHepatocellular carcinomaIntraoperative blood transfusionRecurrenceSurvival

Identifiers

PMID38038790
OpenAlexW4389223328

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.